Correlation Between Pasithea Therapeutics and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Transcode Therapeutics, you can compare the effects of market volatilities on Pasithea Therapeutics and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Transcode Therapeutics.
Diversification Opportunities for Pasithea Therapeutics and Transcode Therapeutics
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pasithea and Transcode is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Transcode Therapeutics
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Transcode Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 1.62 times less risky than Transcode Therapeutics. The stock trades about -0.21 of its potential returns per unit of risk. The Transcode Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 879.00 in Transcode Therapeutics on April 23, 2025 and sell it today you would earn a total of 90.00 from holding Transcode Therapeutics or generate 10.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Pasithea Therapeutics Corp vs. Transcode Therapeutics
Performance |
Timeline |
Pasithea Therapeutics |
Transcode Therapeutics |
Pasithea Therapeutics and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pasithea Therapeutics and Transcode Therapeutics
The main advantage of trading using opposite Pasithea Therapeutics and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Virax Biolabs Group | Pasithea Therapeutics vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |